MACKENZIE FINANCIAL CORP - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 190 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$712,000
+81.6%
55,512
-0.9%
0.00%0.0%
Q2 2022$392,000
-13.5%
55,988
+2.4%
0.00%0.0%
Q1 2022$453,000
-14.8%
54,696
-30.4%
0.00%0.0%
Q4 2021$532,000
+1562.5%
78,618
+621.3%
0.00%
Q3 2020$32,00010,9000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 208,189$1,726,0003.48%
FRIESS ASSOCIATES LLC 571,940$4,741,0002.53%
GABLES CAPITAL MANAGEMENT INC. 438,764$3,637,0002.28%
Prairiewood Capital, LLC 258,073$2,139,0001.50%
Quantedge Capital Pte Ltd 597,300$4,952,0001.46%
ARMISTICE CAPITAL, LLC 8,372,000$69,404,0001.34%
SummerHaven Investment Management, LLC 158,473$1,314,0000.74%
Capital Impact Advisors, LLC 99,322$823,0000.60%
EAM Investors, LLC 365,415$3,029,0000.56%
GLOBEFLEX CAPITAL L P 304,515$2,524,0000.51%
View complete list of CATALYST PHARMACEUTICALS INC shareholders